Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.54
-0.16 (-1.84%)
Apr 29, 2026, 11:42 AM EDT - Market open
Kyverna Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 517 | 537 | 161 | - | - | - |
| Market Cap Growth | 539.67% | 232.60% | - | - | - | - |
| Enterprise Value | 276 | 371 | -151 | - | - | - |
| Last Close Price | 8.70 | 9.40 | 3.74 | - | - | - |
| PB Ratio | 2.26 | 2.31 | 0.61 | - | - | - |
| P/TBV Ratio | 2.27 | 2.31 | 0.61 | - | - | - |
| Debt / Equity Ratio | 0.13 | 0.13 | 0.03 | 0.19 | 0.23 | 0.09 |
| Net Debt / Equity Ratio | -1.08 | -1.08 | -1.04 | -0.99 | -0.87 | -1.13 |
| Net Debt / EBITDA Ratio | 1.49 | 1.49 | 1.98 | 0.80 | 1.43 | 2.74 |
| Net Debt / FCF Ratio | 1.63 | 1.63 | 2.38 | 0.91 | 1.11 | 3.01 |
| Asset Turnover | - | - | - | - | 0.09 | - |
| Quick Ratio | 7.65 | 7.65 | 8.47 | 2.90 | 4.29 | 4.78 |
| Current Ratio | 7.76 | 7.76 | 8.61 | 3.06 | 4.46 | 4.84 |
| Return on Equity (ROE) | -64.67% | -64.67% | -80.74% | -125.95% | -52.95% | - |
| Return on Assets (ROA) | -35.47% | -35.47% | -46.93% | -54.89% | -24.10% | - |
| Return on Capital Employed (ROCE) | -66.00% | -66.00% | -52.60% | -112.80% | -53.50% | -37.90% |
| Earnings Yield | -30.63% | -30.04% | -78.95% | - | - | - |
| FCF Yield | -29.19% | -28.62% | -72.13% | - | - | - |
| Buyback Yield / Dilution | -15.46% | -15.46% | -5590.81% | -47.89% | -71.30% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.